Dermatology · Columbia, SC
NPI
1225532369
Since 2018
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3600 Forest Dr Ste 400
Columbia, SC, 29204
Phone (803) 779-7316
Groups this clinician bills Medicare through
Medicare paid, 2024
$468K
12,927 services
Medicare patients, 2024
2,258
Average age 76
Drug cost, 2024
$1.5M
2,137 prescriptions
Company payments, 2025
$51K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Seth T Howell was code 17003 (destruction skin lesion), 5,388 times for 934 patients. In total Seth T Howell billed 12,927 services in 85 codes, and Medicare paid $468K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 5,388 | 934 | $4.56 | $25K |
| 99213 Office E&M - Established | Office | 2,564 | 1,811 | $55.64 | $143K |
| 17000 Destruction Skin Lesion | Office | 1,772 | 1,268 | $35.17 | $62K |
| 11102 Skin Biopsy | Office | 831 | 683 | $60.65 | $50K |
| 17110 Destruction Skin Lesion | Office | 328 | 295 | $75.57 | $25K |
| 99214 Office E&M - Established | Office | 325 | 267 | $78.36 | $25K |
| 99203 Office E&M - New | Office | 286 | 286 | $61.20 | $18K |
| 11103 Skin Biopsy | Office | 182 | 130 | $33.27 | $6,055 |
| 99212 Office E&M - Established | Office | 144 | 135 | $36.97 | $5,324 |
| 17004 Destruction Skin Lesion | Office | 120 | 93 | $113.83 | $14K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 111 | 29 | $0.71 | $79.28 |
| 17262 Destruction Skin Lesion | Office | 91 | 85 | $121.70 | $11K |
| 12032 Wound Repair - All Levels | Office | 67 | 63 | $219.08 | $15K |
| 11602 Skin Lesion Excision | Office | 54 | 50 | $93.28 | $5,037 |
| 99204 Office E&M - New | Office | 51 | 51 | $99.18 | $5,058 |
By year: 2022 $92K for 2,110 services; 2023 $307K for 8,080 services; 2024 $468K for 12,927 services.
Medicare prescription drug claims, 2024
In 2024, the drug Seth T Howell prescribed most often to Medicare patients was Triamcinolone Acetonide, with 260 prescriptions and refills. In total Seth T Howell wrote 2,137 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 260 | 291 | 198 | $3,572 |
| Clobetasol Propionate Generic | 256 | 274 | 173 | $8,874 |
| Fluorouracil Generic | 124 | 128 | 118 | $7,715 |
| Mupirocin Generic | 105 | 105 | 86 | $682 |
| Hydrocortisone Generic | 101 | 108 | 73 | $1,727 |
| Doxycycline Hyclate Generic | 90 | 126 | 57 | $2,337 |
| Metronidazole Generic | 87 | 97 | 50 | $4,847 |
| Imiquimod Generic | 79 | 81 | 61 | $956 |
| Ketoconazole Generic | 79 | 97 | 48 | $1,330 |
| Cephalexin Generic | 78 | 85 | 60 | $573 |
| Ssd Silver Sulfadiazine | 56 | 57 | 47 | $1,037 |
| Doxycycline Monohydrate Generic | 47 | 61 | 34 | $1,060 |
| Desonide Generic | 43 | 44 | 28 | $1,617 |
| Clindamycin Phosphate Generic | 43 | 47 | 26 | $1,491 |
| Silver Sulfadiazine Generic | 42 | 45 | 30 | $542 |
Brand drugs: 302 claims; generic drugs: 1,835 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Seth T Howell $51K ($51K in general payments such as food, travel and fees) from 15 companies. The largest payer was UCB, Inc. with $50K.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 96 | $50K |
| Abbvie Inc. ABBV | 25 | $338 |
| Regeneron Healthcare Solutions, Inc. REGN | 11 | $154 |
| Lilly USA, LLC LLY | 8 | $135 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 5 | $110 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $100 |
| Genzyme Corporation SNY | 4 | $70.64 |
| Amgen Inc. AMGN | 3 | $60.64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55.13 |
| LEO Pharma Inc. | 2 | $38.66 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.